Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

L. Villa, G. Perez, S. Kjaer, M. Lehtinen, J. Paavonen, N. Munoz, K. Sigurdsson, M. Hernandez-Avila, O. E. Iversen, S. Thoresen, P. Garcia, S. Majewski, E. H. Tay, F. X. Bosch, Joakim Dillner, S. E. Olsson, K. Ault, D. Brown, D. Ferris, A. GiulianoL. Koutsky, R. Kurman, E. Myers, E. Barr, J. Boslego, J. Bryan, M. Esser, T. Hesley, L. Lupinacci, R. Railkar, H. Sings, F. Taddeo, A. Thornton

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials'. Together they form a unique fingerprint.

Medicine and Dentistry